标题
Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
作者
关键词
NGS, Biliary tract cancers; overall survival, <em class=EmphasisTypeItalic >ARID1A</em>, <em class=EmphasisTypeItalic >IDH1/2</em>, <em class=EmphasisTypeItalic >FGFR2</em>, Targeted therapy
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 17, Issue 11, Pages -
出版商
Springer Nature
发表日期
2016-09-22
DOI
10.1007/s11864-016-0432-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mismatch repair protein loss and microsatellite instability in cholangiocarcinoma.
- (2017) Lipika Goyal et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Gallbladder Cancer Incidence and Mortality, United States 1999-2011
- (2015) S. J. Henley et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cancer modelling in the NGS era – Part I: Emerging technology and initial modelling
- (2015) Ugo Rovigatti CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeted Therapy in Biliary Tract Cancers
- (2015) Amartej Merla et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028
- (2015) Y.J. Bang et al. EUROPEAN JOURNAL OF CANCER
- Epigenetic regulation in the carcinogenesis of cholangiocarcinoma
- (2015) Nai-Jung Chiang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets
- (2015) Hwajeong Lee et al. JOURNAL OF CLINICAL PATHOLOGY
- Role of the fibroblast growth factor receptor axis in cholangiocarcinoma
- (2015) Celina Ang JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- HER2/neu-directed therapy for biliary tract cancer
- (2015) Milind Javle et al. Journal of Hematology & Oncology
- Abstract PL04-05: The first reported results of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a Phase I study of patients with advanced IDH1-mutant solid tumors, including gliomas
- (2015) Howard Burris et al. MOLECULAR CANCER THERAPEUTICS
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma
- (2015) L. Goyal et al. ONCOLOGIST
- Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors
- (2015) Cinta Hierro et al. SEMINARS IN ONCOLOGY
- Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
- (2015) Michele Simbolo et al. Oncotarget
- The emerging roles of ARID1A in tumor suppression
- (2014) Ren-Chin Wu et al. CANCER BIOLOGY & THERAPY
- Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
- (2014) D. R. Borger et al. CLINICAL CANCER RESEARCH
- Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma
- (2014) Alexandra R. Grassian et al. CURRENT OPINION IN GASTROENTEROLOGY
- Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification
- (2014) Gia L. Tyson et al. DIGESTIVE DISEASES AND SCIENCES
- Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
- (2014) Rondell P. Graham et al. HUMAN PATHOLOGY
- Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
- (2014) David Malka et al. LANCET ONCOLOGY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
- (2014) Maolan Li et al. NATURE GENETICS
- New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
- (2014) J. S. Ross et al. ONCOLOGIST
- Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
- (2014) Chaitanya R. Churi et al. PLoS One
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Mutational landscape of intrahepatic cholangiocarcinoma
- (2014) Shanshan Zou et al. Nature Communications
- Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
- (2014) Mitesh J. Borad et al. PLoS Genetics
- Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies
- (2013) Claudia Maletzki et al. EUROPEAN JOURNAL OF CANCER
- Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
- (2013) Yasuhito Arai et al. HEPATOLOGY
- Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site
- (2013) Felipe A. Castro et al. INTERNATIONAL JOURNAL OF CANCER
- High throughput molecular profiling reveals differential mutation patterns in intrahepatic cholangiocarcinomas arising in chronic advanced liver diseases
- (2013) Sejin Jang et al. MODERN PATHOLOGY
- Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
- (2013) Waraporn Chan-on et al. NATURE GENETICS
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
- (2013) Yuchen Jiao et al. NATURE GENETICS
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- Gallbladder Cancer in the Netherlands: Incidence, Treatment and Survival Patterns since 1989
- (2012) Caroline D.M. Witjes et al. DIGESTIVE SURGERY
- Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
- (2012) Benjamin R. Kipp et al. HUMAN PATHOLOGY
- Exome sequencing of liver fluke–associated cholangiocarcinoma
- (2012) Choon Kiat Ong et al. NATURE GENETICS
- Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
- (2012) P Wang et al. ONCOGENE
- Tumours associated with BAP1 mutations
- (2012) Rajmohan Murali et al. PATHOLOGY
- Fibroblast growth factors and their receptors in cancer
- (2011) Jørgen Wesche et al. BIOCHEMICAL JOURNAL
- Risk factors for cholangiocarcinoma
- (2011) Gia L. Tyson et al. HEPATOLOGY
- Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
- (2011) Jeeyun Lee et al. LANCET ONCOLOGY
- Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
- (2009) James E. Everhart et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started